ePlex Blood Culture Identification Panel Fungal Pathogen (BCID-FP) Panel— 510(k) K182690

Substantially Equivalent

Genmark Diagnostics, Incorporated

FDA 510(k) clearance K182690 for ePlex Blood Culture Identification Panel Fungal Pathogen (BCID-FP) Panel, Substantially Equivalent on 2018-12-21. Applicant: Genmark Diagnostics, Incorporated.

Clearance details

Applicant
Genmark Diagnostics, Incorporated
Product code
Code PEO
Advisory panel
Microbiology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Carlsbad, CA, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.